133 related articles for article (PubMed ID: 9237175)
21. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
[TBL] [Abstract][Full Text] [Related]
22. Skin metastases revealing a bilateral ovarian invasive micropapillary serous carcinoma.
Moussa A; Denguezli W; Njim L; Haddad A; Faleh R; Sakouhi M; Zakhama A
Arch Gynecol Obstet; 2008 Jul; 278(1):71-4. PubMed ID: 18066568
[TBL] [Abstract][Full Text] [Related]
23. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case].
Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J
Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890
[TBL] [Abstract][Full Text] [Related]
24. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
Shvartsman HS; Sun CC; Bodurka DC; Mahajan V; Crispens M; Lu KH; Deavers MT; Malpica A; Silva EG; Gershenson DM
Gynecol Oncol; 2007 Jun; 105(3):625-9. PubMed ID: 17320156
[TBL] [Abstract][Full Text] [Related]
26. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases].
Yao Z; Li L; Yang H
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039
[TBL] [Abstract][Full Text] [Related]
27. [Strategy and outcome of interdisciplinary therapy of ovarian carcinomas].
Ruf C; Kohlberger E; Bauknecht T; Farthmann EH
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1494-6. PubMed ID: 9931922
[TBL] [Abstract][Full Text] [Related]
28. Minimal change disease in a patient with ovarian papillary serous carcinoma.
Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
[TBL] [Abstract][Full Text] [Related]
29. [A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis].
Mizutani H; Katabuchi H; Nakamura M; Matsuura K; Ito M; Okamura H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1139-42. PubMed ID: 8245594
[No Abstract] [Full Text] [Related]
30. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
31. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
32. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
33. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
Tavassoli FA
Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
[TBL] [Abstract][Full Text] [Related]
34. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
35. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
37. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
Afify AM; Werness BA; Mark HF
Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
[TBL] [Abstract][Full Text] [Related]
38. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
39. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
40. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
Bristow RE; Duska LR; Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
